You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

~ Buy the EDETATE CALCIUM DISODIUM Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

EDETATE CALCIUM DISODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Edetate Calcium Disodium patents expire, and what generic alternatives are available?

Edetate Calcium Disodium is a drug marketed by Casper Pharma Llc and is included in one NDA.

The generic ingredient in EDETATE CALCIUM DISODIUM is edetate calcium disodium. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the edetate calcium disodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Edetate Calcium Disodium

A generic version of EDETATE CALCIUM DISODIUM was approved as edetate calcium disodium by CASPER PHARMA LLC on May 3rd, 2023.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EDETATE CALCIUM DISODIUM?
  • What are the global sales for EDETATE CALCIUM DISODIUM?
  • What is Average Wholesale Price for EDETATE CALCIUM DISODIUM?
Drug patent expirations by year for EDETATE CALCIUM DISODIUM
Recent Clinical Trials for EDETATE CALCIUM DISODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 1
National Cancer Institute (NCI)Phase 1
Mt. Sinai Medical Center, MiamiPhase 4

See all EDETATE CALCIUM DISODIUM clinical trials

Pharmacology for EDETATE CALCIUM DISODIUM

US Patents and Regulatory Information for EDETATE CALCIUM DISODIUM

EDETATE CALCIUM DISODIUM is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting EDETATE CALCIUM DISODIUM

COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc EDETATE CALCIUM DISODIUM edetate calcium disodium INJECTABLE;INJECTION 216435-001 May 3, 2023 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.